Production (Stage)
NanoSphere Health Sciences Inc.
NSHS
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -123.86% | 1,076.98% | 31.75% | -47.94% | 24.77% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 110.13% | -2,906.04% | -241.09% | -56.71% | 210.78% |
| Change in Net Operating Assets | -25.36% | 892.06% | -81.05% | 242.78% | -73.02% |
| Cash from Operations | 450.34% | 68.99% | -359.02% | 128.75% | 180.81% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 280.00% | -106.49% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 280.00% | -106.49% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -890.00% | 22.81% | 254.05% | 59.78% | -217.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.96% | 10.09% | -174.66% | 1,316.67% | 42.86% |